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Abstract
The importance of health research utilisation in policy-making, and of understanding the
mechanisms involved, is increasingly recognised. Recent reports calling for more resources to
improve health in developing countries, and global pressures for accountability, draw greater
attention to research-informed policy-making. Key utilisation issues have been described for at
least twenty years, but the growing focus on health research systems creates additional dimensions.
The utilisation of health research in policy-making should contribute to policies that may eventually
lead to desired outcomes, including health gains. In this article, exploration of these issues is
combined with a review of various forms of policy-making. When this is linked to analysis of
different types of health research, it assists in building a comprehensive account of the diverse
meanings of research utilisation.
Previous studies report methods and conceptual frameworks that have been applied, if with varying
degrees of success, to record utilisation in policy-making. These studies reveal various examples of
research impact within a general picture of underutilisation.
Factors potentially enhancing utilisation can be identified by exploration of: priority setting;
activities of the health research system at the interface between research and policy-making; and
the role of the recipients, or 'receptors', of health research. An interfaces and receptors model
provides a framework for analysis.
Recommendations about possible methods for assessing health research utilisation follow
identification of the purposes of such assessments. Our conclusion is that research utilisation can
be better understood, and enhanced, by developing assessment methods informed by conceptual
analysis and review of previous studies.
Review
Introduction and Background
The Director General of the World Health Organization
(WHO) has decided that the World Health Report 2004,
Health Research: Knowledge for Better Health, should in-
volve a careful reflection of how advances in health
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WHO has launched a broad Health Research Systems
Analysis (HRSA) Initiative that will inform the 2004 re-
port. One component of this initiative is a project focus-
ing on the assessment of health research utilisation. The
utilisation project itself consists of various elements. This
paper was commissioned by the Research Policy and Co-
operation Department of WHO, Geneva, to review the is-
sues related to the utilisation of health research in policy-
making, and, based on that review, make recommenda-
tions about appropriate methods for assessment of such
utilisation.
WHO is giving increased emphasis to the role of health
systems [1] and attention is focusing on the importance of
policy-making in achieving effective health systems [2,3].
The World Bank made estimates of the costs of attaining
the health-related Millennium Development Goals of be-
tween $20 and $25 billion a year. However, the report
notes that: 'these unit cost estimates only apply when the
policy and institutional environment is conducive to ad-
ditional health spending being effective' [2]. The impor-
tance of health policy-making, in turn, being research-
informed is recognised by a growing number of bodies
[3–5].
The existence of relevant research, though necessary, is not
sufficient. Evidence-based policy is difficult to achieve and
it is widely agreed that health policies do not reflect re-
search evidence to the extent that in theory they could [5–
11]. Examination of the policy-making process confirms it
to be extremely complex, with many genuine obstacles to
evidence-based policy-making at the same time as there
are factors that could increase research utilisation. A full
review of the many possible meanings of research impact
reveals that there may be more utilisation in policy-mak-
ing than is sometimes recognised. Such a review also en-
hances understanding of the issues, including the
differential scope for utilisation associated with different
types of research and policy environments. Developing a
conceptual framework of the processes of utilisation
should assist with the formulation of assessment tools
that reveal the full picture of the way research is used in
policy-making. Furthermore, it should allow the growing
demands for accountability for research expenditure [12–
18] to be addressed appropriately, which could also be of
benefit to the research community.
There is a rich background of material for each of these ar-
eas, including key contributions from Weiss identifying
the multiple meanings that can be attached to research
utilisation in policy-making [19]. Their importance lies in
the fact that some of these meanings, or models, point to
less obvious patterns of use than those suggested by in-
strumental research exploitation which involves research
findings being directly used in policy formulation.
About twenty years ago there was recognition of the need
for analysis to combine a range of factors such as the na-
ture of different types of health research knowledge and
the diverse institutional arrangements for policy-making.
In their assessment of the attempt in the 1970s to increase
utilisation of research funded by the UK's Department of
Health, Kogan and Henkel found, 'the interconnections
between epistemologies and institutional relationships
were a recurring theme' [7]. The importance of interac-
tions across the interfaces between researchers and policy-
makers was identified. The role of policy-makers as the re-
ceivers, or receptors, of research and the need for careful
priority setting were highlighted. Various elements of this
analysis were recently reported also to be relevant for
health research in Mexico [10].
The context of the current move to attempt to increase re-
search utilisation is important. There is now a broad coa-
lition pressing for improvements. Various organisations
came together in 2000 to support the formation of the Al-
liance for Health Policy and Systems Research with its 300
partner institutions. It aims to promote capacity building
for, and the dissemination and impact of, research both
on and for policy [20]. At the level of specific programmes
within international bodies, there is a growing stress on
the role of policy-making: 'Research on implementation,
on policy-making or programme development is as im-
portant as basic clinical research for improving child
health' [21]. Recent weeks have seen publication of the
first systematic review to address research utilisation in
policy-making [22]. Furthermore, the developing interest
in research informed policy-making coincides with the ex-
tensive efforts being made to increase the implementation
of health research findings more generally. Indeed, the
emphasis on evidence-based medicine is itself generating
extra pressure from practitioners that policy-makers, too,
should have a duty to consider research evidence [23]. The
role of research utilisation in policy-making is seen as a
key element in the growing interest within WHO on re-
search utilisation and its assessment [3,24].
A further important part of the context is that develop-
ments in the UK in the 1970s, and in other European
countries [25], could be seen as early attempts to develop
a system to augment the traditional individualistic deter-
mination of medical research priorities in universities and
hospitals. A similar emphasis on issues such as priority
setting is seen in recommendations made for middle and
low income countries by the Commission on Health Re-
search for Development [26]. The concept of Health Re-
search Systems (HRSs) is now of growing significance
[27]. One of the main elements that distinguishes a HRSPage 2 of 28
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cilitate the greater use of health research.
Building on the above analysis, it is our contention that
many factors need to be brought together if assessment of
research impact on policy-making is to contribute to an
understanding of the issues and an enhancement of utili-
sation. The prime focus should be the policy-maker. This
paper first examines the concept of policy-making, and
the underlying assumption that it is better if it is research-
informed. Then we consider the range of types of health
research and the levels of policy-making at which they
could be applied. These strands are brought together to
provide an analysis of the wide range of ways in which re-
search can have an impact on health policy-making.
The focus then moves to examining contributions from
previous studies of knowledge utilisation in health policy-
making, including those using standardised measures.
Various dimensions of our conceptual analysis form the
next sections. We start with the interfaces, both at the pri-
ority setting stage and when findings are communicated
between researchers and policy-makers. The role of poli-
cy-makers as receivers, or receptors, of research is exam-
ined along with the accompanying institutional
arrangements. Incentives are also important. The material
is brought together in a wide-ranging interfaces and recep-
tor model of research utilisation in policy making. Finally,
the various possible purposes of assessment of research
utilisation are considered before suggestions are made
about suitable methods for assessing the impact of re-
search on policy-making. Such assessments would be best
undertaken as part of a wider evaluation of the utilisation
of health research by industry, medical practitioners and
the public.
The nature of policy-making and its role in knowledge 
utilisation
Policy-making can be viewed as involving the 'authorita-
tive allocation of values' [28], and when interpreted
broadly can include people making the policy as govern-
ment ministers and officials, as local health service man-
agers, or as representatives of a professional body. Policy-
making involves those in positions of authority making
choices that have a special status within the group to
which they will apply. The results take many forms rang-
ing from national health policies made by the govern-
ment to clinical guidelines determined by professional
bodies. This broad usage of the term policy-making has
advantages when conducting knowledge utilisation or
payback assessments, and has contributed to a conceptual
framework for a series of such studies [14,17,29]. In this
article, however, the analysis mainly concentrates on pub-
lic policy-making rather than that undertaken by profes-
sional bodies.
This framework consists of two elements. These are a mul-
tidimensional categorisation of benefits from health re-
search, going through from the primary and secondary
outputs to the final outcomes, and a model of how to as-
sess them. A revised version of the model is shown as Fig-
ure 1 and consists of a series of stages. This sequence can
be useful when examining how a health research project
could be utilised, in policy-making and practice, in ways
that result in final outcomes such as health gains and eco-
nomic benefits. Public engagement with research can play
a key role in research utilisation. The model incorporates
the concept of the stock, or pool, of knowledge and the
idea that there are various interfaces between research and
the wider political, professional and social environments.
These points, together with various feedback loops and
forward leaps, mean that although the stages are present-
ed in a linear form, the model recognises that the actual
steps involved in utilisation and achieving final outcomes
are often multidirectional and convoluted. That said, the
model helps both to organise assessments and to indicate
where the various elements of the multidimensional cate-
gorisation of benefits might occur.
The framework is also important for the structure of this
article because it demonstrates that assessment of research
impact on policy-making is best undertaken as part of a
wider analysis of the utilisation of research. Throughout
the paper it will become increasingly clear that policy-
making is itself influenced by industry, by health profes-
sionals who might be expected to apply research findings
in their practice, and by the public who might engage with
research, either as patients or more generally in society.
The interaction of all these groups with research findings
is an important consideration and the interfaces operate
at many levels.
In terms of the utilisation of the knowledge, research-in-
formed policies can be referred to as secondary outputs
from research [14]. This distinguishes them from the pri-
mary, or direct, outputs of research processes such as jour-
nal articles, other publications, and trained researchers.
Neither, however, are the policies the desired final out-
comes; they represent a step in the process. It is sometimes
possible to identify how research findings have informed
policy-making even when it might be extremely difficult
to trace influences at other stages in the utilisation proc-
esses. Furthermore, the approach enables the processes of
research utilisation to be identified in ways that would be
impossible if the analysis attempted to jump immediately
to the final outcomes. In particular, detailed analysis at
this stage can address the counterfactual, ie consider what
might have happened without the relevant research:
would the policy have been changed anyway?Page 3 of 28
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The Place of Policy-Making in the Stages of Assessment of Research Utilisation and Final Outcomes.
Key:
Direct lines within the flow or feedback 
Indirect lines of communication 
Primary Outputs – Publications, trained researchers
Secondary Outputs – Policies from national, local and professional bodies
Final Outcomes – Health and equity gains, cost-effectiveness and economic benefits
Source: Adapted from S Hanney, S Kuruvilla: HRSPA Project 4: Utilisation of research to inform policy, practice and public understand-
ing and improve health and health equity. WHO/Wellcome Trust Technical Workshop. London, January 2002; and S Hanney et al 
2000, Evaluation, 6, published by Sage [29].
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through a policy-making stage, and in some cases the pol-
icy comes after partial translation of the findings into
practice. For example, clinical guidelines are usually
developed after leading clinicians in the field have already
adopted an evidence-based practice and then seek to en-
courage its wider diffusion throughout the profession.
Nevertheless, often a policy-making stage in knowledge
utilisation is important if the final outcomes of health,
health equity, and social and economic gain are to be
achieved. The potential importance of a policy stage in the
process of turning evidence into application is increasing-
ly being accepted, even for clinical practice [30].
A positive case can be set out for the contribution research
can make to policy-making. The basic assumption of
knowledge utilisation related to policy-making is that pol-
icies which are research informed will be better than oth-
erwise would have been the case. It is assumed that
research exposes policy-making to a wider range of vali-
dated concepts and experiences than those that can be
drawn from the normal time-limited and politically con-
strained processes of policy deliberation. It thus allows a
broader choice of policy options to emerge. Research of-
ten enables policies to be generated upon technically well-
informed bases. It gives warnings of reasons why some
policies succeed and others fail. It can make connections
between otherwise separate factors such as the nature of
the substantive field and organisational patterns set up to
manage them, or the power of environments over health
outcomes. It legitimises some policies and throws legiti-
mate doubts on others. Analysis of policy-making, and of
research utilisation, often identifies at least three broad ar-
eas of activity: policy agenda setting, policy formulation,
and policy implementation [11,31]. Potentially, research
could play a part in all three areas. Evaluation is also often
seen as an important activity, and one that adopts a re-
search approach. Indeed, in this paper evaluation is pri-
marily being viewed as a form of research, the utilisation
of which will be examined in the other phases of policy-
making.
Davies and Nutley, in a recent analysis of the role of evi-
dence, or 'What Works', in a series of public services, sug-
gest 'the research community in healthcare is truly global,
and the drive to evidence-based policy and practice is pan-
demic' [32]. Of the public services, health care is seen as
the one where, despite the difficulties, the utilisation of
knowledge is most advanced. Although this analysis does
examine a range of policy-making models, critics claim
that the theoretical basis for evidence-based policy-mak-
ing is not strong because it rests too much on a rational
view of policy-making [33,34]. The debate needs to be in-
formed by various models of policy-making such as those
set out below.
Many categorisations of policy-making exist. The categori-
sation of policy-making presented here is not intended to
describe the models comprehensively. Instead, it is based
on previous analyses of public policy-making that were
specifically made in the process of analysing research uti-
lisation. The categorisation incorporates work undertaken
by Kogan and Tuijnman [35], for the Organisation for
Economic Co-operation and Development, and by many
others [9,36–38]. The various models described are not
mutually exclusive, but are included because each makes
a specific contribution that is built on in later analysis:
Rational models
Rational models of policy-making assume policy-makers
identify problems, then gather and review all the data
about alternative possible solutions, and their conse-
quences, and select the solution that best matches their
goals. Sometimes this approach is known as ends-means
rationality; it is thus different from some of the models
below which might, nevertheless, also seem rational to
the policy-makers involved. The various models of policy-
making should be seen as a spectrum. Thus Simon [39] is
sometimes seen as writing from the rationalist tradition,
but he was critical of the more basic rational models and
his concept of 'bounded rationality' involves concentrat-
ing the review of data on a more limited range of possible
solutions.
Incrementalist models
It has long been recognised that policy-making is a com-
plex process. It can involve scientific knowledge and a
range of other factors including interests, values, estab-
lished positions within institutions, and personal ambi-
tions. Furthermore, evidence from research has to
compete with what Lindblom and Cohen [40] call 'ordi-
nary knowledge' which owes its origins to, 'common
sense, casual empiricism, or thoughtful speculation and
analysis'. In models such as 'disjointed incrementalism'
[41] policy-making does not involve a clear movement to-
wards predetermined goals but rather is more a series of
small steps in a process of 'muddling through' [42] or 'de-
cision accretion' [43]. Incrementalists allow for a greater
role for interests in policy-making debates and emphasise
the many sources of information that impinge on policy-
makers.
Networks
A networks approach also highlights the role of different
interests and how the relationships between such groups
and policy-makers can result in an incremental policy
process. The term 'policy network' is defined as a generic
label for the different types of state/interest group rela-
tionships, for example 'policy communities' in which the
long term relationships between government officials and
representatives of leading interest groups are particularlyPage 5 of 28
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involve a wider membership and are more likely to in-
clude researchers. It is claimed that researcher
involvement in 'social networks' [47] is important for re-
search utilisation. Others suggest that leading experts who
share a similar approach on an issue can be seen as an
'epistemic community' [48] and can influence policy.
Analysis of health systems often suggests the influence of
the medical profession over policy-making is particularly
strong [49]. Its domination of the policy networks led to
the use of the term 'a professionalised policy network'
[50,51]. Its influence is likely to be a factor in setting agen-
das and determining the type of knowledge to which most
notice is taken in the policy debate.
The 'garbage can' model
The 'garbage can' model of policy-making [52] looks at
these issues in an idiosyncratic way. It suggests that some-
times solutions that might have been disgarded neverthe-
less remain in the policy-making system, and occasionally
there are problems to which they become attached. Mod-
els such as this highlight the way in which policy-making
can be seen as a most untidy process, rather than neatly
going through a series of phases [53].
These various models of policy-making, even occasionally
the final one, are likely to be found relevant to different
circumstances and parts of health systems. They will have
different implications for the utilisation of research and
although they do not stack up as connected paradigms, or
have much predictive power, they help put shape onto
otherwise inchoate patterns. We shall explore how far
they specifically map on to models of research utilisation
after considering the range of overlapping categorisations
of health research.
Categories of health research and possible levels of 
utilisation
The categorisation of health research discussed here has a
potential importance for the analysis of utilisation. Often
a broad distinction is made between basic, clinical and ap-
plied research. By its nature basic, or blue-skies, research
is not often likely to be utilised until further, less basic, re-
search has been undertaken and perhaps some synthesis
with other findings has occurred. Research that follows
priorities determined by the researchers themselves, ac-
cording to the 'internalist' norms of science [54], is more
often, though not always, going to be basic. Applied re-
search is more likely than basic research to be following
an agenda driven by forces other than the scientific imper-
ative. Just because the research topic has been set by non-
researchers does not, of course, ensure its impact. Never-
theless, where such drivers and sponsors are also the most
likely potential users of the research, this provides some of
the circumstances that might encourage utilisation
[7,53,55].
There is generally greater resistance within health services
to the use of social science, despite it often being applied
and user-driven, than there is to the adoption of the find-
ings from natural sciences [7,10] such as those used in
clinical science. Possible explanations include the fact that
the more highly technical and specific the research, the
more there might be circumstances in which it can be uti-
lised directly by policy makers without ideological or po-
litical considerations intervening too much. Moreover,
the receptors of research are likely to place more confi-
dence in the strictly controlled natural sciences than in the
more eclectic social sciences. Much of policy-making can
be seen as a craft, which draws substantially on ordinary
knowledge and in which the contextual component will
often be more significant than the type of evidence offered
by social science research [56].
Another partially overlapping distinction is between na-
tional and international research. International research
findings might be more likely to be utilised where there is
greater technical content in the research and also potential
for application to an issue of patient care. The report of the
Commission on Health Research for Development also
identified the particular contributions that national and
global health research could make [26]. It developed the
concept of Essential National Health Research (ENHR).
This entails a strategy in which each country plans its
health research according to country-specific health prob-
lems and the contribution it can make to regional and glo-
bal health research. Mechanisms for the synthesis or
systematic review of research might become even more
important in relation to international research.
Adding to the epistemological debate about the most ap-
propriate forms of production of knowledge intended for
utilisation, Trist [57] argued that domain-based research
represented a third category alongside basic and applied
research. Domain-based, or policy-oriented, research is
essentially interdisciplinary and the crossing of new
boundaries and the creation of new syntheses may ad-
vance both knowledge and human betterment. It also en-
tails wider reference groups, beyond the scientific or
clinical communities. Along similar lines, Gibbons et al
[58] claim to identify a shift from the traditional disci-
pline-centred mode of knowledge production that they
characterise as Mode 1, towards a broader conception of
knowledge production described as Mode 2. In this,
knowledge is generated in a context of application and ad-
dresses problems identified through continual negotia-
tion between actors from a variety of settings. The results
are communicated to those who have participated in their
production. Although the degree of change described byPage 6 of 28
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proach, as with that of Trist, is compatible with attempts
to increase utilisation by focusing research production on
the interests of at least some potential users.
A slightly different dimension, but one also associated
with utilisation, is that of the features of specific research
studies. When a particular piece of research is seen to be
of high quality this might help reinforce a policy-maker's
inclination to use it [14,60], as might a favourable view
about the quality of the specific researcher [10]. The argu-
ment, as developed by Weiss and Bucuvalas, is that where
the policies are potentially controversial the decision-
makers will not want the credibility of their case under-
mined by critics pointing to flaws in the research behind
the policy [60]. When Ministers in the UK supported ac-
tions to address gender inequalities in the medical profes-
sion, they did so with full confidence in the quality of the
research that demonstrated the problem [61]. Examina-
tions of the use of economic evaluations and Health Tech-
nology Assessments (HTAs) in policy-making have
considered the importance of the quality, reliability, time-
liness and comprehensiveness of research in influencing
the level of utilisation [62–67]. For example, the latter two
factors were highlighted as important determinants of the
usefulness of the information in the context of drug for-
mulary decisions in the USA [68].
Different types of research are likely to be most relevant
for various levels and situations of policy-making, and for
different aspects of those policies. There is no agreed ty-
pology of policy categories suitable for utilisation assess-
ment [11]. Above, we suggest that the interpretation of
policy being adopted here covers national policies, local
health service policies and policies made by professional
bodies. Along not dissimilar lines Black [34] argues that
an earlier threefold categorisation [69] could be appropri-
ate when examining health research and policy-making.
The three categories are: governance policies which relate
to organisational and financial structures; service policies
which cover resource allocation issues and pattern of serv-
ices; and practice policies which relate to the use of re-
sources by practitioners in delivering patient care. A
similar division appears in the threefold categorisation
proposed by Lomas: 'legislative, administrative and clini-
cal' [70]. Legislative policies relate to the overall frame-
work for organising health services; administrative to the
running of the service and allocation of resources within
the overall framework; and clinical to the policies about
what therapies are applied. These categorisations are best
seen as a spectrum, but it is generally agreed that research
has least impact on the first of these categories and most
on the third where often the relevant knowledge comes
from clinical research. This is despite the frequent delays
in turning research evidence into improved patient care
[71,72].
Some of the issues in this section are illustrated in relation
to Health Technology Assessments (HTAs). Various fea-
tures of HTAs might be associated with the sometimes
quite high levels of translation into policy-making and
through into the final outcomes [14,73–75]. Many HTAs
are undertaken, commissioned, or produced by technolo-
gy 'sponsors' specifically for agencies set up to advise gov-
ernmental bodies setting policies for delivering patient
care in national health systems. Frequently they address a
very specific question that has been identified and priori-
tised by the health care system: presumably, a question to
which the system wants an answer, and by implication is
willing and able to accept alternative outcomes if they can
be supported by evidence.
Whilst these HTAs are 'technical' in the sense that they
typically relate to quantitative measures of effectiveness
and cost-effectiveness of specific interventions, they do
have important distributional and equity implications.
Policies deriving from them may induce strong public and
patient reactions (as is evident in media coverage of pro-
posed guidance from bodies such as The National Insti-
tute for Clinical Excellence in the UK). This emphasises
the need in such systems to differentiate between the re-
search activity of health technology assessment and the de-
cision-making (or guidance forming) process of appraisal
of that evidence and its implications [76].
But even for HTA the evidence of widespread, direct im-
pact on policy (with policy seen as entirely convergent
with the research evidence) is at best patchy. A study in the
Netherlands by van den Heuvel et al [77] concludes that
policy decisions concerning the introduction of (new)
technologies in health care are not based on the results of
medical technology assessments. Rather, 'political argu-
ments and interest groups decide the outcomes'. In a re-
cent literature review, Barbieri and Drummond [78]
found few examples of HTA impact in European health
care systems. At the local level, those involved in making
policies about the introduction of new medical technolo-
gies are likely to view the contribution that effectiveness
research can make in different ways, depending on their
professional backgrounds [79]. This discussion under-
lines the fact that even in the circumstances most favour-
able for 'rational' policy-making there are limitations
upon it. This indicates the need to consider the full range
of models of research utilisation.
Models of research utilisation
Having reviewed various models of policy-making in the
second section, and examined different types of research
in the third section, it will now be useful to considerPage 7 of 28
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can see how far the various strands from these sections can
be drawn together and developed in our later construction
of a conceptual framework. We start by looking at previ-
ous models of research utilisation, and then suggest ways
in which they could be elaborated.
Following the work of Weiss [19,80], and others
[7,14,37,38,55,81,82], various models of research utilisa-
tion in policy-making have been identified, and they are
thought to be applicable beyond the social sciences:
The classic/purist/knowledge-driven model
This suggests a linear sequence in which research gener-
ates knowledge that impels action.
The problem-solving/engineering/policy-driven model
This also follows a linear sequence, but begins with the
identification of a problem by a customer who requests
the researcher to identify and assess alternative solutions.
This was explicitly the model behind the changes attempt-
ed by the UK Department of Health in the 1970s [7].
The interactive/social interaction model
The process here is a set of interactions between research-
ers and users rather than a linear move from research to
decisions. It ensures they are exposed to each other's
worlds and needs.
The enlightenment/percolation/limestone model
According to this, research is more likely to be used
through the gradual 'sedimentation' of insight, theories,
concepts and perspectives. This model has the advantage
of extending the range of ways in which research is seen to
be utilised.
The political model
In this, research findings become ammunition in an ad-
versarial system of policy making.
The tactical model
Here research is used when there is pressure for action to
be taken on an issue, and policy-makers respond by an-
nouncing that they have commissioned a research study
on the matter. Whilst this can sometimes be seen as a cyn-
ical delaying tactic, there are other occasions on which the
commissioning of research provides the political system
with a valuable breathing space, thus reducing the chances
of irrational policy-making.
There is no precise overlap between the principal charac-
teristics of policy-making models discussed earlier and the
utilisation processes listed above such as would allow
them to be presented in neat pairs of singletons. The first
two categories of utilisation both fit with rational models
of policy-making, but it is the problem-solving model that
shares the same starting point: identification of a problem
by a policy-maker. The more incremental models of poli-
cy-making have the longer time frame implied by interac-
tive and enlightenment models of utilisation, but
sometimes these forms of utilisation lead to paradigm
shifts which are much more radical than is inherent in
incrementalism.
Policy networks are seen as providing a useful framework
for studying research utilisation [36]. Where researchers
become part of a policy network, or find their ideas taken
up by elements within it, this could be a strong version of
the interactive model and be an important route for such
findings to enter the policy arena. Network approaches
can highlight the role of stakeholders in research utilisa-
tion [9,14]. (The network concepts could also, however,
help to explain the difficulties some research faces in gain-
ing acceptance, or even a hearing. Policy-making systems
can be relatively impermeable to research findings that are
contrary to the consensus developed as a result of the
strong, long-term, links between departmental officials
and leaders of the main interest groups).
It is of value to explore the variety of policy-making/utili-
sation connections because they underline the argument
that it is not realistic to expect policy-making always to
follow the ends-means rational model that might entail
the clearest use of research. Weiss also suggests that there
are three main forms in which research might appear and
be utilised in policy-making: as data and findings; as ideas
and criticism in the enlightenment mode; or as briefs and
arguments for action [83]. Along similar lines the utilisa-
tion of research in policy-making is sometimes considered
to be instrumental, conceptual or symbolic [11]. As we
have seen, instrumental use involves research findings be-
ing directly used in policy formulation, conceptual use re-
fers to a type of enlightenment mode of utilisation, and
symbolic to the use of the research to support a position
already taken, which may be to continue with existing
policies.
Taking another of Weiss's arguments, that utilisation of re-
search can be usefully be defined as a process of interac-
tion between research inputs and decision outputs [43],
we next elaborate the range of possible uses of research.
Given the diversity of forms of knowledge and policy de-
cision, their interaction has to be understood in the con-
text of both the diverse values shaped by philosophies of
knowledge and the practical aspects of policy-making.
With regard to the former, policy-makers may privilege
empirical findings against more abstract and general mod-
els of reality. In terms of policy-making it is useful to dis-
tinguish three dimensions: the nature of decisions, that is,
the extent to which they are explicit and specific versusPage 8 of 28
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en situation; and the political or technical character of ac-
tors participating in decisions. These are shown on Figure
2 and developed below but it is useful to consider the cat-
egories as a spectrum.
Sometimes policy-makers make rational and weighted de-
cisions along a well charted course of action, yet more of-
ten apply knowledge through largely routine or
unconscious processes in response to ad hoc situations;
here the context is implicit rather than explicit. A situation
of choice will exist when several alternatives are perceived
as viable, contrasting with a situation where a decision has
been taken and the role for research is rather to support
this choice. Support in turn covers two types of situation.
Specific findings can be used to legitimate decisions when
these have been formed, have hardened or when they are
being implemented. In relation to the concept of models
referred to above, support is more a matter of explicit pol-
icies being seen to be made by institutions that are re-
search-based and therefore the policies gaining greater
credibility. Political decisions are normally justified in
terms of social values and understandings shaped in the
political arena, but there can be a role for scientific inputs
in the policy formulation. Technical decisions are those
that are expected to be justified in terms of scientific or
specialised methods.
The combination of diverse forms of scientific inputs and
decision outputs shapes the processes of utilisation and
creates specific expectations and opportunities. The com-
ponents of Figure 2 are expounded in more detail as
follows:
Conceptual modelling
Knowledge to inform complex situations is frequently de-
manded in the form of concepts to model or shape the
general nature of the policy problems and possible solu-
tions. Planning health sector reforms or identifying health
policy in areas normally outside its purview, such as pov-
erty or economic development, are likely to demand such
knowledge, as they provide new disciplinary or social per-
spectives on a given problem and activate new associa-
tions and meanings for policy issues [84]. They can be a
first step to other forms of research utilisation.
Data-based policy
This form of utilisation aims to influence courses of action
on the basis of the strength of empirical findings. Scien-
tists may take the lead through a 'knowledge-driven' ap-
proach, or policy-makers can demand such knowledge to
solve specific problems ('policy-driven' model). In either
case scientific rigour, robustness and objectivity would be
principles trusted by both researchers and policy-makers.
Figure 2
Decision Context, Research Inputs and Forms of Research Utilisation in Policy-Making

	 
		

	



	







	




	















	


	
	

	


Page 9 of 28
(page number not for citation purposes)
Health Research Policy and Systems 2003, 1 http://www.health-policy-systems.com/content/1/1/2Constrained modelling
Constrained political conditions give rise to utilisation
that, from the perspective of researchers, uses only a re-
stricted range of available knowledge. Likewise, policy-
makers will not commission or will discourage research
that, in its broad outlines, poses more political risks than
benefits [85].
Strategic research
Policy is most often formulated in a context where lay (as
opposed to technocratic) actors vie for power and resourc-
es. The choice of policy may be open, but only through
politically controlled windows of opportunity. Under
these circumstances the ultimate validity of research will
be assessed together with other and often competing evi-
dence. The aim of researchers is usually to influence policy
choice or to make explicit the costs of not adopting a rec-
ommended course of action [86].
Symbolic payback
Science has become a potent cultural symbol that perme-
ates modern life and confers privileges on its users. Like-
wise, there is a political pay-off in supporting research and
building research capacity in strategic areas. Research has
become 'an essential mode of communication and
persuasion in the public arena' [43]. In complex organisa-
tions, research could be a common language used to talk
across the boundaries of interests and content areas given
its capacity to effectively link disparate realities and be-
cause of 'the patina of rigor that science confers to dis-
course'. This might suggest that policies from bodies
known to be research-informed might be more likely to
be supported.
Symbolic argumentation
Policy making may be based mainly on reasons of inter-
est, ideology or intellect. Under these circumstances, how-
ever, research can still be used as ammunition to support
the decisions made and being implemented. Science con-
tent is here used as a collection of arguments, rather than
as data or evidence to be weighed. Arguments may be
fashioned as by-products of formal research publications,
particularly by policy analysis units, consulting firms and
the media [87].
Paradigms
Given the large measure of unconscious elements in eve-
ry-day decision making, accepted ways of interpreting re-
ality and facing problems are the most important
influence. An aggregate of normative expectations may
amount to an overriding view of what is desirable health
policy, such as those advanced in Welfare State thinking.
Such policy paradigms may be triggered off or supported
by single or grouped assumptions derived from research,
which also may achieve paradigmal status. Individual pol-
icies are likely to reflect the dominant paradigms of their
time.
Policy-Makers' practice wisdom
How far individual policy-makers will automatically at-
tempt to use research findings on a regular basis will de-
pend on multiple influences, such as training, continuous
education, exposure to the media and to the demand of
clients.
Although these categories are not water-tight, they help
indicate the breadth of types of research utilisation and,
therefore, areas on which any assessment methods should
focus.
Various elements from this and preceding sections will be
particularly useful as we develop our own conceptual
framework for analysing and assessing research utilisation
in the context of the increasing attention on HRSs. For ex-
ample, the importance, but also the limitations, of the
problem-solving model must be considered when exam-
ining the role of research priority setting. Furthermore, in
light of the practical limitations on rational models, the
importance of interactive perspectives will be highlighted
as a way of encouraging policy-makers to be responsive to
relevant research. Overall, both these points, and others,
suggest that it is appropriate to focus on the actions that
could be taken to encourage permeability at the interfaces
between policy-makers and researchers. Such actions
should help ensure both that researchers are aware of pol-
icy-makers' needs, and that the policy-making system is
willing and able to absorb relevant research findings.
It is also possible to link some of the ideas in this section
to the three phases of policy-making referred to earlier:
agenda setting; policy formulation; and policy implemen-
tation. For agenda setting the research could impact in
one of several ways. Research could demonstrate the exist-
ence or extent of a problem, through either specific find-
ings or a process of enlightenment. Alternatively, it could
be that, as in the knowledge-driven model, the mere gen-
eration of the findings leads to pressure to act upon the
new knowledge. The use of research in policy formulation
could be in either the instrumental or conceptual/ enlight-
enment mode. A further possibility is that it could be used
as briefs to inform arguments as set out in the political
model of research use. The implementation of health pol-
icies is widely acknowledged often to be difficult [37,53].
At the implementation stage, research could play some
part in demonstrating the best way to implement policy
and could inform decisions. It could also be of symbolic
use in helping to build support for implementation
through assistance with communicating or justifying the
policy and being used to generate support for it in termsPage 10 of 28
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opinion.
Before developing the material into a conceptual frame-
work and methods for assessment of utilisation, it will be
useful to review the focus and methods adopted in previ-
ous studies of policy-making. This review will provide ex-
amples of where wide interpretations of utilisation have
been incorporated into studies of the impact of research.
Contributions from selected previous studies of health pol-
icy-making and knowledge utilisation
Studies of the nature and impacts of policy-making can
each exploit a wide range of analytic methods. The area
covered by them is extensive and here we review one
study: that of policy change in relation to health financing
reforms in South Africa and Zambia [31]. It illustrates sev-
eral of the approaches that can be applied when analysing
policy-making in general, and is included here as a back-
drop to the accounts, immediately following this one,
specifically on research utilisation in policy-making. The
case study in each country was organised according to a
conceptual framework consisting of a process of policy
change moving from, Gilson et al state, 'agenda setting
around a reform of focus, to reform design, and then
through implementation to the achievement of
immediate and longer term changes' [31]. The policy
analysis approach of Walt [37,88] was also drawn upon so
that the factors influencing each stage of the reform proc-
ess were categorised and analysed according to four broad
factors: context, actors, process and content.
In the two countries data were collected through: docu-
mentary analysis; key informant interviews with policy-
makers and analysts; media analysis; and review of sec-
ondary sources. The data analysis techniques included:
development of a timeline for each reform; stakeholder
analysis; policy mapping techniques; impact analysis
through use of secondary data; and a review process. The
two case studies incorporated examination of the impact
on the policy development made by research analysts,
both inside and outside government, and found it to be
'strongly dependent upon the presence of a policy cham-
pion' [31].
This section now draws selectively upon a review of a wide
range of previous studies specifically about research utili-
sation in health policy. From this several key themes are
discussed:
• focus of the study;
• how far the study was based around a conceptual frame-
work and how far comparisons or conclusions were
drawn;
• methods and standardised measures used in assessing
impacts and outcomes;
• levels of utilisation and other benefits shown.
Focus of the study
Studies that start with the research project or programme,
and examine the impact that it has had [14,17,75,89,90],
have the advantage of a reasonably tightly defined focus.
They can be of use for research funders, but often run into
the problem that any impact research makes is usually of
a contributive nature and it is difficult to identify the im-
pact of one project or programme from that of others with
which the findings get mixed [16]. Other studies consider
the portfolio of researchers' work over a particular period
[91], or the contribution of specific health research centres
[29,92–95]. Studies such as these lend themselves to net-
work analysis.
Health policy-makers have been the focus of studies.
Some examine the policy-makers' use of research in gen-
eral [96]. Others can involve health policy-makers, for ex-
ample in mental health, being shown research papers
describing evaluations of programmes and then asked
how useful they would find such research [60]. Drum-
mond et al asked local policy-makers about their attitude
to using economic evaluations in general, and whether
they had used specific evaluations [65]. A major way in
which impact on policy has been assessed is through stud-
ies that start with a policy area, or theme, and then seek to
identify how far the policy-making or implementation
has been informed by research [11,77,96–102]. Focusing
on the policy area has the advantage of facilitating some
assessment of how far lack of relevant research is the prob-
lem, as opposed to the underutilisation of existing
research.
The two broad approaches, starting with research or start-
ing with policy, have elements of overlap. A study of the
role of research in the regulation of private health care
providers in an Indian state focused on the activities of a
key research centre [103]. In some studies of the impact of
research on particular health care programmes, interviews
with researchers produce examples of how their own re-
search has been utilised [10,104]
Some studies have cases from a range of countries and
have been organised by, or involved, international bodies
including the Council on Health Research for Develop-
ment (COHRED) [5], the European Union (EU) [101],
and the Cochrane Collaboration [102]. Other studies ex-
plicitly take examples from two or more sub-national
units [11]. Many studies cover a series of examples from
the same country or sub-national unit.Page 11 of 28
(page number not for citation purposes)
Health Research Policy and Systems 2003, 1 http://www.health-policy-systems.com/content/1/1/2Conceptual framework and comparisons
Some of the most illuminating studies are organised ac-
cording to a conceptual framework. Thus Landry et al [91]
attempted to operationalise Knott and Wildavsky's Ladder
of Knowledge Utilisation which suggests there are six stages
of utilisation [105]. These are: transmission, cognition,
reference, effort, influence, and application. Generally,
studies that adopt a conceptual framework involve a series
of cases. Buxton and Hanney [14,17,29,106] organised
several series of studies around the conceptual framework
described in Figure 1. Walt's framework for analysing
health policy-making [88], described earlier, was used to
organise impact studies in Mexico [10]. The EU-funded set
of studies in developing and developed countries [101]
was based around a conceptual framework, as described
by Sauerborn et al [9], that concentrates on analysis of the
role of the various interests or stakeholders.
A key feature of all these studies is that the conceptual
framework facilitates comparable analysis of the results. A
considerable amount of this analysis is drawn upon else-
where in this paper, but one example is given here. Les-
sons were learnt from the EU-funded studies regarding:
factors enhancing or hindering research use; possible indi-
cators to measure research use; and possible strategies to
increase such use. However, it has become clear that mak-
ing generalisations is difficult because of country specific
factors such as differing contexts (including the political
system and culture), differing stakeholder constellations,
and differing availability and quality of research. A con-
clusion, therefore, is that careful consideration of these
factors, rather than recipe-like approaches, will be needed
for successful enhancement of the use of research. (A. Ger-
hardus-personal communication). Similarly, Berridge and
Stanton [107], after reviewing various case studies that
were not undertaken as part of a set, identify a series of fac-
tors considered important in the research/policy relation-
ship. They go on, however, to note that 'they are
necessarily historically determined, and culture and con-
text specific, rather than part of a reproducible general for-
mula for action' [107].
There are clear tensions in our analysis between recogni-
tion of the genuine limitations in the ability to make gen-
eralisations and a desire to learn as much as possible from
comparisons. It is useful, therefore, to note the findings
from a study that addresses the issue of how far analysis
from developed countries might be appropriate else-
where. Trostle et al found there were various issues where,
in comparison with developed countries, there could be
different emphases in Mexico and 'in other developing
country contexts' [10]. Nevertheless, most of the factors
that Husén and Kogan [108] had identified as encourag-
ing utilisation of educational research in industrialised
nations were, they state, 'also found to be important in
our study. These included decision-makers' willingness to
consider research results as input for decision-making,
and political stability...and the existence of research net-
works or commissions which provide a favourable arena
for interaction between research and decision-making'
[10].
Methods and standardised measures used in assessing impacts and 
outcomes
The two methods used most frequently, and usually used
together, come from the qualitative tradition: documenta-
ry analysis and in-depth interviews
[10,11,14,63,75,77,97,98,104]. The need for having the
flexibility interviewing can provide is well illustrated by
studies in which the original interview schedule had to be
amended to take account of the different perspectives held
by policy-makers of the role of research [79]. Interviewing
is useful for understanding many aspects of research utili-
sation, including tracing networks between researchers
and users [90].
Some studies use insider knowledge [94,102] and there
has been some adoption of questionnaires to researchers
about the utilisation of their work [11,106]. Particularly
where the policy-making is at a local level, questionnaires
have been used and administered either by phone [68] or
by post [65]. In the latter case, Drummond et al also at-
tempted to assess the problem of inaccurate responses.
They included two fictitious studies in the list sent to pol-
icy-makers, and almost 20% claimed to have seen these
studies; some of those admitted to having been influ-
enced by them [65]. Bibliometric analysis is sometimes
incorporated into broader studies [106] and, in an analy-
sis of the papers that were cited in clinical guidelines,
Grant et al specifically adopted a bibliometric approach
[109]. Historical approaches have also been adopted
[99,107] and allow a more contextualised analysis. The
methods used are diverse, and only partially depend on
the focus and purpose of the studies. The list of studies de-
scribed here partially overlaps with, but is not identical to,
those 24 included in the recent systematic review [22].
The 24 include a greater proportion that use question-
naires administered either by phone or post, but still face-
to-face interviews form the majority.
There have been a few recent attempts to scale or score the
degree of impact. Four such studies are described below,
starting with two where the focus of each case study was a
specific piece of research. An assessment of the impact of
HTAs in Quebec used a case study approach [75]. Initially
seven levels of critical incidents were identified. The im-
pact of each HTA was scored on the basis of documentary
analysis, and the information completed and validated
through contact with key witnesses. In this way, Jacob and
McGregor explain, 'by taking into consideration the levelPage 12 of 28
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impact on policy was awarded to each HTA. This was re-
ported in a scale extending from 0 (no impact) to
+++(major impact). The weight awarded to critical inci-
dents was adjusted according the nature of the decision at
issue' [75].
Despite the largely, though not exclusively, qualitative
methods used by Buxton and Hanney, in one study they
attempted to score the impact made by projects on the ba-
sis of material from questionnaires [106]. This was partial-
ly validated by re-scoring those projects for which more
detailed information became available from case studies.
The correlation was quite good at an overall level, though
there were differences in both directions at the individual
project level. This scoring was entirely a methodological
exercise and the results for specific projects were not
identified.
Lavis et al coded their interview material according to
whether the research had been used at agenda setting and/
or policy formulation stages, and whether the research
had impacted on all the policy or only partially [11].
The above three examples involved members of the as-
sessment team undertaking the scoring and coding. The
EU-funded project described by Gerhardus et al developed
a model for mapping research to policy flows based on the
qualitative case studies. From this model a set of numeri-
cal indicators was devised which entailed scoring by both
the assessment team and stakeholders [101]. The inten-
tion, in what is probably the most methodologically am-
bitious research utilisation study included in this review,
was that the indicators would be used in each of the eight
countries to facilitate comparisons between research utili-
sation before and after interventions aimed at increasing
such utilisation. In each country a policy was identified
along with the content, conclusions and recommenda-
tions of the relevant research. Next, a series of questions
was put to the stakeholders and points allocated accord-
ing to their recall of the content etc. Further points were al-
located depending on the references to the research made
in speeches, statements, guidelines and similar sources. Fi-
nally, the stakeholders were asked to rate on a five-point
scale a range of factors, including research, that influenced
their decision making [101].
Preliminary results from the study suggest that conceptu-
ally the set of indicators has proven to be helpful, but
problems with computation of the indicators arose due to
the generally small sample of stakeholders interviewed.
There were also problems related to the data collection for
applying the knowledge-related indicators. This part of
the stakeholder interviewing frequently created a possibly
stressful, or even embarrassing, exam-like situation and in
some cases revealed problems due to the considerable re-
call period involved when probing about older pieces of
research. The body of indicators developed in the project
was quite large, and it is considered appropriate to reduce
it to a simplified set of core indicators (U. Sunderbrink –
personal communication).
Level of utilisation and final outcomes
The examples suggest a greater level of utilisation and fi-
nal outcomes in terms of health, health equity and social
and economic gain than is often assumed, whilst still
showing much underutilisation. There is considerable
variation, both within and between studies. The study of
the role of research in child health policy and pro-
grammes in Pakistan [104] found some examples of im-
mediate clear-cut linkage between research and decisions,
but in general the view was that research was little utilised.
A mixed picture was reported in the Mexican studies: bio-
medical or clinical research was thought to be 'a critical re-
source for decision-making in each of the four
programmes', but the importance of other types of re-
search varied [10]. Of the eight policies examined in two
Canadian provinces, four seemed to have been influenced
by research, for example, in terms of agenda setting, re-
search identified the need for increased pneumococcal
immunisation in Saskatchewan [11]. Research utilisation
is also demonstrated in some of the primarily insider-ac-
counts, including that by Phoolcharoen [94] describing
the role of the Health Systems Research Institute in Thai-
land in enabling research to impact on the reform of the
health system.
Considerable utilisation is reported in some of the studies
that focus on specific pieces of research. For two of these
sets of studies, a wide interpretation of utilisation in poli-
cy-making was used [14,17,89,106], and one focused ex-
plicitly on evaluative research [89]. In some, but not all,
such cases there was purposive selection. The study of the
HTAs in Quebec showed over 85% had had an impact on
policy [75]. The latter study is also one of the compara-
tively few to trace through from impact on policy to actual
outcomes or benefits. It was suggested there had been cost
savings of between $16 and $27 million annually. The
Buxton and Hanney studies also attempted to trace
through to the outcomes although this proved difficult. In
one case, the evidence suggested that the research had
strongly influenced the policy on heart transplantations.
Buxton was able to estimate the increased number of QA-
LYs (Quality-Adjusted Life Years) that resulted from the
programme being properly funded and organised, as op-
posed to the counterfactual which might have been a less
substantial and piece-meal development of heart trans-
plantation in the UK [110].Page 13 of 28
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of the studies have clearly shown an improvement in
health equity as a result of policy changes: 'research has
also played an important role in the expansion of Medic-
aid to poor pregnant women, young children, the elderly,
and disabled' [111]. Other studies have not only demon-
strated a major impact on policy but also been able to de-
scribe how research led to a paradigm shift [95].
The review of previous studies is now build upon in the
following section as we develop our conceptual frame-
work for assessing the level research utilisation in policy-
making.
The interfaces between the health research system and 
policy-makers: priority setting and research commissioning
Increasing attention is focusing on the concept of interfac-
es between researchers and the users of research
[6,7,14,29,93,112]. This incorporates the idea that there
are likely to be different values and interests between the
two communities [113], with their different time-frames
[6,7], and that research is less likely to be utilised in a sig-
nificant way unless networks and mechanisms are estab-
lished at the interfaces. One version of the interfaces
concept is presented in Figure 1. The 'permeability of the
interfaces' [14] becomes important given the potential
problems in the transmission of views and findings be-
tween researchers and policy-makers. Issues around inter-
faces need to be considered at various stages including
priority setting, commissioning of research and commu-
nication of the findings.
The power relationship between publicly funded research-
ers and policy-makers may be described in terms of an ex-
change relationship [114]. The policy-maker receives new
knowledge, and the testing of existing knowledge, in re-
turn for providing resources and public legitimacy. If the
exchange becomes imbalanced, a reduction in the value of
its outcomes becomes likely. Some of the analysis below
attempts to identify both ways of enhancing the exchange,
and the items upon which any assessment of utilisation
should focus.
As shown in Figure 1, however, the picture is broader than
this because many of the research findings flow into the
pool of knowledge. Furthermore, some research that is
potentially of use to policy-makers will not have been
funded by them. This includes research from the interna-
tional stock, which highlights the role of research as a glo-
bal public good [3]. If a national system is to draw on this
to maximum benefit, various interface mechanisms might
be needed. This section, however, describes a mechanism
specifically related to user-driven research, and the next
section covers the broader interfaces.
It is not necessary here to describe all the expert approach-
es to research priority setting – see The 10/90 Report on
Health Research, 2001–2002 [4] for a recent review. Given
all the current activities, however, it is important to con-
sider problems identified in previous attempts to enhance
utilisation through priority setting [7]. Resistance to prior-
ity setting comes from those who adopt the 'internalist'
view of research. They share Polanyi's opinion that the
best science comes from the freedom of the researcher to
pursue the priorities that emerge from the scientific im-
peratives [115]. Most now accept the contention, as
voiced by Kogan and Henkel, that if health research is 'in-
ternalist and freely sponsored, the problem for govern-
ment will be that of securing adequate brokerage with
it...because it has not taken part in the setting of problems'
[7].
In addition to the technical questions to do with how best
to identify the most important priorities in terms of health
needs, the utilisation aspects of the debate perhaps re-
volve around two key questions:
• are priorities being set that will produce research that
policy-makers and others will want to use?
• are priorities being set that will engage the interests and
commitment of the research community?
Research that Policy-makers will be more likely to use
Policy-makers have not always found it easy to identify
their needs or to aggregate the demands from various
sources [7]. Again, the limitations on the ends-means
model of rationality must be recognised and it should not
be assumed that sophisticated priority setting mecha-
nisms will automatically produce research regarded as rel-
evant by policy-makers. This is why it is so important that
the methods described do incorporate stakeholder in-
volvement and an iterative approach [4], and that, partic-
ularly when overseas agencies/researchers are involved,
efforts are made to link the research to the priorities of the
national policy-makers [21]. This should boost local own-
ership of the research. From the perspective of the policy-
maker it is important that the research not only seems rel-
evant, but also timely. Involvement in such priority set-
ting is itself sometimes seen as a way of informing policy
[7]. Any assessment of utilisation should include identifi-
cation of policy-makers' attitudes towards the priorities
set.
The ability of policy-makers to set priorities, and the like-
lihood of them using the eventual research findings, will
probably be increased if they are able to develop long-
term links with researchers. This is especially the case for
researchers in centres where they can build up their own
shared reservoir of knowledge on the key issues andPage 14 of 28
(page number not for citation purposes)
Health Research Policy and Systems 2003, 1 http://www.health-policy-systems.com/content/1/1/2discuss this with policy-makers [14,29,103]. In these cir-
cumstances, researchers help develop the policy-makers'
views about what are the important issues that should be
addressed by research. Crucially, this allows researchers to
play an interactive role in shaping policy-makers per-
ceived needs.
Priorities to engage the commitment of researchers
There is a danger that the more the agenda is set unilater-
ally by non-researchers, the less the research community
will be committed to working on it. At the commissioning
interface between priority setting and the funding of spe-
cific pieces of research, there is some scope for subtle de-
fection from the agreed priorities [116]. It is possible that
the move towards Mode 2 research [58] means that an in-
creasing number of researchers are moving away from be-
lief in the superiority of the internalist Mode 1 approach.
Where the policy-makers are working with the researchers
as suggested by Trist [57] and Gibbons et al [58] this could
result in research that has more chance of being utilised,
but much of Gibbons et al's analysis is not related to for-
mal priority setting exercises. Iterative research commis-
sioning processes [34,117] and priority setting [4] might
be ways of addressing both problems identified in this
section.
Finally, despite the importance of priority setting, there is
no monopoly of wisdom and those who wield the enor-
mous power of government do well to foster their own
critics and counter-analysis [7]. Independent research can
provide critical commentaries and alternative perspectives
that are important for healthy policy-making in the long
term.
The interfaces between the health research system and 
policy-makers: transfer of research to policy-makers
Much previous work stresses the importance of interac-
tions between policy-makers and researchers in increasing
the likelihood of attention being given to the knowledge
produced. This continues the above discussion and fits es-
pecially well with Weiss's interactive model [19], and with
the view that policy-makers are unlikely to take much no-
tice of research if the first they know about it is when it ar-
rives on their desk [89]. It is claimed that previous
interaction increases the possibilities of the findings mov-
ing up the Ladder of Research Utilisation [105], and that the
building of bridges between researchers and policy-mak-
ers is important and could be achieved by 'decision-linked
research' [6,118].
The studies described earlier provide many examples to
support this analysis, including discussion of 'linkage
strategies' [104], and 'interactions' [11]. A cholera re-
searcher is quoted in the Mexican study as saying: ' "if
there isn't a good relationship between a researcher and a
decision-maker...it is difficult for research results to be
taken into account" ' [10]. Buxton's insider account of his
own work evaluating the emerging UK heart transplanta-
tion programme illustrates the benefits that can come
from close liaison with the potential users [110,119]. As a
result of frequent liaison the Department of Health knew
the likely results of the final report. Then, on the day it was
received, a major decision was made to fund a full heart
transplantation programme in the UK, the benefits of
which were described earlier. This demonstrates that al-
though building interactive relationships is often a long-
term endeavour, it can result in rapid policy-making.
Some of the studies provide examples of how good inter-
action was achieved through informal communications as
a result of deliberate actions by researchers or even
through chance relationships [10]. Researchers them-
selves sometimes provide policy briefing for policy-mak-
ers, which is seen as a useful but underdeveloped
approach [53]. The existence of researchers, or research re-
sponsive members, in policy networks can also be impor-
tant. These can be international [120]. These types of
observations are broadly supported by some of the three
most commonly mentioned facilitators of the use of re-
search in the 24 studies included in the systematic review.
The three are: personal contact between researchers and
policy-makers (13/24); the timeliness and relevance of re-
search (13/24); and the inclusion of a summary with clear
recommendations (11/24) [22].
The various actions of individuals can be important, but it
is desirable to consider the role of the HRS in encouraging
or facilitating interactions, networks and mechanisms at a
system-wide level. Priority setting approaches are one
such mechanism. The development of long-term research
centres focusing on particular topics [10,14,29] is one of
the potentially strongest ways a HRS can take action to in-
crease the possibilities of research being used to inform
policy. Here the concept, noted above, of 'epistemic com-
munities' [48] is useful and has explicitly been applied to
assessments of the benefits from health research centres
[29]. Furthermore, accounts from various countries or
provinces describe the importance being attached to the
creation of an institute for health research. Examples in-
clude: Mexico [6]; Thailand [94]; Canada [121] and Mani-
toba, Canada [93]. The desirability of such institutes
engaging with stakeholders is being addressed by the Alli-
ance for Health Policy and Systems Research [122]. Once
established, such links can build on mutual respect and
help develop an understanding of the differing
perspectives.
HRSs could also ensure long-standing committees or fora
are formally established to allow scientists and policy-
makers to discuss issues. These could operate at bothPage 15 of 28
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key policy-makers are aware of relevant research. Such ap-
proaches have been used in various countries including
the UK [7] and Burkina Faso [9]. Other brokerage mecha-
nisms that could also be provided by the HRS include ar-
ranging seminars for policy-makers, and funding
individuals to act as research brokers [7,80,123], or trans-
lators [12,82]. Such individuals, who may be in key
knowledge management roles within the HRS, take the
findings from researchers and bring them to the attention
of policy-makers and others. It is useful to think of diffu-
sion of the findings at several levels. In addition to direct-
ing findings at policy-makers within the health system,
efforts at wider diffusion might also help build support
for adoption of the findings.
Whatever the direction of the dissemination, however,
mechanisms are needed that review and synthesise re-
search and attempt to identify the research that should be
promoted from that that should not. HRSs have a clear re-
sponsibility in this area in terms of funding such reviews
and their dissemination; the latter through a range of
mechanisms including the internet. It can go further than
this, however, and the attempt to provide some structure,
or 'knowledge warehouse' [29], to the pool or stock of
knowledge should be seen as a key knowledge
management function of the HRS. The international Co-
chrane Collaboration plays an important part in this, and
was inspired by the UK Cochrane Centre that was a mech-
anism funded as part of the information system of the
UK's HRS [124,125]. The need to use and develop data-
bases of evidence, and reviews of research, has been ex-
plored in relation to preparing evidence to inform policies
on the reduction of health inequalities [126].
Many, but not necessarily all, of the mechanisms for trans-
mission of the relevant national and international re-
search are the responsibility of the HRS to provide. Some
of the above considerations are important in the interface
between national health systems and international re-
search and international bodies promoting health. In
drawing conclusions from the COHRED studies, Chun-
haras comments: 'National research co-ordinating bodies,
such as the ENHR mechanisms promoted by COHRED,
can also play a mediating role to better foster research to
policy linkages. International agencies too have an impor-
tant contribution to make as intermediaries in linking
knowledge and action' [110]. The integration of research
into the health care programmes of international organi-
sations can be an effective mechanism for research-in-
formed policies to be brought about [21].
The role of policy-makers as receptors of research
There is increased recognition of the significance of poli-
cy-makers in their role as recipients, or receptors, of re-
search [7,9,11,104,112,127,128]. Despite the low
response rate to their questionnaires, the findings from
Landry et al's study illustrate this point. They claim: 'fac-
tors such as dissemination and linkage mechanisms that
are generally considered to be powerful explanatory fac-
tors and to be the most efficient targets for policy interven-
tions are less important than factors such as the receptive
capacity of users when one climbs from the stage of trans-
mission to the higher stages in the ladder of knowledge
utilisation. Future research must recognize that the same
factors do not explain success at all stages of knowledge
utilisation' [91].
Beyer and Trice [129] also set out a series of steps policy-
makers go through when using research and this has been
applied to health research [11,62]. Epistemological, social
and institutional issues are all relevant to the role of the
research receptor [7,128]. The types of research relevant to
policy-making vary greatly. The key questions could be
seen as a spectrum:
• is there research available that is either relevant to policy
issues, or could help bring new issues onto the agenda?
• is such research being effectively brought to the atten-
tion of policy-makers in diverse positions within the
health system?
• is the policy-making system capable of absorbing the re-
search findings?
• are there situations where the policy-makers are willing,
and able, to use it?
The HRS can assist here in the various ways described, but
the wider policy system has a responsibility to create the
right institutional mechanisms and staff capacity. Broad-
ly, the responsibility of the HRS is greatest in the first part
of this spectrum. It is recognised that it is much more dif-
ficult to make recommendations about how to increase
the use of research in the development and implementa-
tion of policy, than it is to suggest how to improve com-
munications [10]. There is, however, no neat division of
responsibility. The main thrust of our analysis is that the
issues need to be addressed on a system-wide basis, and
that there is a series of measures the HRS can take to max-
imise the possibilities of research utilisation. These in-
clude encouraging policy-makers to see the benefits in
general, and in specific situations, of using research to
help build a policy environment which will result in im-
provements in the health system.
Institutional arrangements do matter [6,7]. A policy ma-
chine must face the problems involved in using research,
some of which it will not have commissioned itself. ItPage 16 of 28
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cern a policy problem that might yield to disciplined en-
quiry. To some extent these needs might be met by the use
of scientific or policy advisers from outside the policy-
making body, but they may not have full access to the gen-
erative stage of policy development. Hence the need for
internal brokerage. These might be officials with either a
scientific or a professional or a policy-making back-
ground. The evidence is that, whatever their provenance,
they may be able to assume the skills and value-set of
boundary-crossers and research enablers [7]. Some have
become famous for their ability to empathise with the
needs, problems and potentials of researchers whilst ena-
bling policy-makers to secure otherwise inaccessible skills
and knowledge [130].
The response of policy-makers to research varies not just
with the type of issues and research being dealt with, but
also with the differing attitudes they adopt towards the
whole policy-making process [113]. As individuals, some
policy-makers are much more receptive to research than
others. The issues are wider than individual preferences,
however, and also depend on: how far the research ac-
cords with the political and social zeitgeist of the time
[128]; the national political and administrative culture
[10]; and the institutional arrangements for policy-mak-
ing. The historical study from Uruguay demonstrates the
detrimental effect military dictatorship can have on re-
search utilisation [99]. By contrast, the study from South
Africa illustrates how, despite the problems, the new po-
litical environment can help foster the better use of re-
search in the policies related to some programmes [98].
There will be clear opportunities for research findings to
have greater impact when they are in tune with the wider
developments of the time, but there are also dangers that
such research could sometimes be accepted and acted
upon without sufficient analysis to test its validity.
There are variations in patterns of bureaucratic recruit-
ment and other characteristics that can influence research
utilisation. In the countries where the research and policy
connections are strongest, the relationship has been en-
hanced by the fact that some of the senior administrators
have had research experience or interests as part of their
prior education [131,128]. This should make mutual in-
stitutionalisation of the relationship easier to secure. The
willingness of officials to undertake policy analysis is seen
as important [7]. In some systems specific policy analysis
units [132], or think tanks of researchers [9], are estab-
lished in health policy-making bodies. An important de-
terminant of their success will be their position within the
policy-making organisation.
Too often, however, officials in policy-making bodies are
resistant to research because they display strong distrust of
information generated outside the organisation or system
[133]. Furthermore, the career patterns of policy-makers
are often not compatible with strong research utilisation
if the latter depends on developing long term relations to
boost receptivity. Given the length of many research
projects, the original sponsor of research is often not in
place when the findings are reported. Patton, the arch pro-
ponent of making evaluations more likely to be used
through being utilisation-focused, notes that the major
problem with his approach is the frequent turn-over of the
primary intended users [134]. Various studies support a
greater emphasis on training of policy-makers, at least
those in bureaucratic positions [9,10]. If such training fos-
ters a more positive attitude towards the use of research
findings, where relevant, in the policy-making system as a
whole, this could mitigate some of the problems.
There will be situations, particularly where the policies are
likely to be made at local level, where there is much less
likelihood that the researchers will have the opportunity
to develop an interactive relationship with potential poli-
cy-makers. Several consequences flow from this. As noted
previously, the characteristics of specific pieces of research
can become important determinants of its uptake. There is
an onus on the HRS to ensure it identifies and publicises
those characteristics of research that are likely to increase
its appeal to policy-makers. It should encourage such re-
search to be undertaken.
In some countries there are specific mechanisms that lead
to the incorporation into policy instruments of research
such as Health Technology Assessments (HTAs) and clin-
ical trials. This is one of the reasons noted previously for
the greater likelihood of HTAs making an impact. A col-
laborative working group examining these issues in Eu-
rope concluded that, whilst they were able to identify
occasional examples of systematic integration of HTA in
decision-making structures, there was no direct link be-
tween the amount of money spent on HTA and its impact
on the decision-making process [67]. Indeed, they suggest
that small programmes can be involved in the core of the
policy-making structure whilst larger HTA programmes
have difficulty in demonstrating impact.
It seems clear that HTAs have had most impact in those
situations where there are specific mechanisms in place
that require research evidence to support well-defined
policy decisions on provision, coverage or reimbursement
(and these impact on practice where there are further
mechanisms to ensure local adherence to national poli-
cy). The European countries where there is some evidence
of such integration include: Germany, Spain, Switzerland,
Sweden and, despite our earlier example, the Netherlands
[67]. Conversely, HTA has had much less impact where
these specific mechanisms are not in place and policy-Page 17 of 28
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manner.
Governments that set up what could be considered ration-
al policy-making arrangements in which primacy is given
to the role of research evidence might find the results face
considerable criticisms in the media. Even with a popula-
tion fully engaged in the cost effectiveness/rationing de-
bate, there would still be scope for disappointed interests
to campaign against decisions. This illustrates the desira-
bility of an integrated approach to utilisation and an
awareness of all the pressures on policy-makers.
In the context of the above discussions more attention
should be given to the role of incentives, both for re-
searchers to produce utilisable research [6] and for policy-
makers, at the system or individual level, to pay attention
to it. In an exercise of empirically based modelling,
Bardach [56] assumed classical economic rationality on
the part of individual policy-makers. He showed how re-
search reaches those for whom its utility exceeds the disu-
tility of obtaining it and noted that co-operative
relationships grow up with research consumers when
producers try to reduce the cost to them of obtaining
information.
Engaging in 'useful' research produces some clear benefits
for researchers. It may be a source of satisfaction that one's
work is being taken notice of and contributing to the for-
mation of policy or the improvement of practice. At
present, however, it is widely thought that the traditional
academic criteria still dominate the crucial assessments of
research performance upon which career advancement
and peer recognition depend [7,29,98,135,136]. The as-
sessment of utilisation, therefore, could become a key is-
sue if rewards are to focus on relevance as well as research
excellence [6,137].
The interfaces and receptor model
Any assessment of the utilisation of health research in pol-
icy-making has to integrate two factors: an awareness of
the wider influences on policy-makers and a detailed anal-
ysis of the specific ways the HRS could contribute to im-
proving the health system through providing the research
to inform policies. An appropriate model for assessing re-
search utilisation in policy-making is also likely to be one
that combines both an emphasis on the importance of ac-
tions at the interfaces and an analysis of the role of recep-
tors. As we have seen there are many models already in
existence. We are proposing an interfaces and receptor
model because it allows a range of key issues to be inte-
grated into the analysis. These include:
A focus on the need for multi-layered analysis
Multi-directional interactions with practitioners and the
public are important for policy-makes and augment the
crucial interface, for research utilisation in policy-making,
between the HRS and the policy system. As noted above,
this interface itself has various dimensions including: pri-
ority setting; research commissioning; and the transfer of
research findings to policy-makers.
An appreciation that both researchers and policy-makers have their 
own values and interests
Therefore, for example, priority setting has to be sophisti-
cated to maximise the likelihood that the research com-
munity will be engaged on a research agenda producing
knowledge that the policy-makers will use. Similarly, just
because research centres undertake large scale dissemina-
tion does not necessarily guarantee their research will be
utilised [11]. Hence the importance of analysis that goes
beyond examining dissemination and considers the na-
ture of productive interactions and the characteristics of
research to which receptors are responsive.
An emphasis on the role of the receptor
This is necessary because ultimately it is up to policy-mak-
ers to make the decisions; this can be a convoluted process
with many stages at which research could potentially have
a role. Again as described above, there are various features
of the organisation and training within the receptor (or
policy-making) body that can enhance the utilisation of
research. Even though responsibility lies with the recep-
tors, the HRS should take every action possible to facilitate
the use of the research. These are important considera-
tions for any assessment of the success of the HRS in rela-
tion to utilisation. First, because they highlight the wider
political context which is beyond the control of the HRS.
Second, because they still leave room for assessments of
the activities of the HRS, within its given context, to in-
crease the permeability at the interfaces [14] and thus pro-
mote the uptake of the research findings by the receptors.
An approach that facilitates analysis of the key paradox highlighted 
by the systematic review
Innvær et al concluded that, 'two-way personal communi-
cation, the most common suggestion, may improve the
appropriate use of research evidence, but it might also
promote selective (inappropriate) use of research evi-
dence' [22]. This potential problem can be addressed in
several ways through the interfaces and receptor model.
First, links between researchers and policy-makers should
ideally develop on a long-term basis so that together at the
priority setting interface they produce a research agenda
that reflects some synthesis between the needs of policy-
makers and the perspectives of independent research anal-
ysis. Second, the interfaces and receptor model emphasis-
es the importance of the role of organisational andPage 18 of 28
(page number not for citation purposes)
Health Research Policy and Systems 2003, 1 http://www.health-policy-systems.com/content/1/1/2training issues such as the need for capacity to undertake
systematic reviews and policy analysis within any system.
While such capacity is seen as a way of enhancing the abil-
ity of the receptors to absorb research, it should also allow
proper analysis of all evidence to be undertaken.
There could, therefore, be value in having assessments of
utilisation that integrate the modelling of research utilisa-
tion with the epistemological, social and institutional
analysis [7] inherent in concepts such as interfaces and re-
ceptor functions. This might contribute to future research
policies and strategies in such a way as to promote greater
utilisation.
Purposes of assessing the utilisation of research in health 
policy-making
Before showing how all the previous analysis could be
built upon in the generation of appropriate tools for the
assessment of the nature and extent of knowledge utilisa-
tion in health policy-making, it is desirable to consider the
purposes of such assessments. The purpose of the assess-
ment is likely to differ depending on the level at which it
is conducted.
Buxton and Hanney [14,15] identified three main reasons
for undertaking their case study, and more general, assess-
ments of the benefits from research:
• justifying spending resources on health research;
• assisting with the prioritisation of future expenditure;
• indicating ways to improve the conduct and manage-
ment of research so as to increase the likelihood or mag-
nitude of subsequent beneficial consequences.
These considerations are particularly relevant when the as-
sessment is related to the justification of, and accountabil-
ity for, funding at a national level, even if the case studies
are conducted at project or research unit level. For a body
such as the WHO, there could well be an important role
in conducting such assessments with the aim of providing
evidence of the possibility of the effective use of research
resources. This could support advocacy for greater resourc-
es to be made available for health research. Such advocacy
has recently been powerfully made as part of the report
from WHO's Commission on Macroeconmics and Health
[138]. This report is seen as convincing [139], and thus
perhaps is helping to generate a more promising climate
in which research utilisation could be assessed. Cross-na-
tional studies of research utilisation around common
themes might be the best way to conduct assessments that
could illustrate effective ways in which health research can
be used. Understanding could be gained from the com-
parisons between and within countries. The potential link
with advocacy would be strengthened if the policies on
which the studies were based were specifically in those ar-
eas where the Commission is calling for increased re-
search funding. These areas include: reproductive health,
maternal and child health, tropical diseases, and health
systems research.
We noted previously the increasing WHO focus on the im-
portance of research informing key policy areas [3,21];
this perspective is shared by WHO regions, for example, in
relation to policies for improving health equity [140]. In
this context it is important to recognise the claim, made in
section 8, that assessment can influence the activities giv-
en priority by researchers. This is likely to be particularly
relevant when the focus of the evaluation is the perform-
ance of specific research units, teams, or even individuals,
especially when funding is at stake. Given this, it is argued
that moves towards giving more importance to the assess-
ment of utilisation of health research should help encour-
age researchers to devote effort to activities likely to
stimulate impact, and reward those who are already doing
so [7,29,136]. The greater the significance of the assess-
ment, however, the more dispute there will be over the
methods to use.
In particular, the role of numerical indicators needs to be
considered in relation to the purposes of the assessment.
It is argued that if the indicators used in performance eval-
uation lack 'decision relevance' they are ignored [141].
The introduction of performance indicators into a process
such as research may, however, have a dysfunctional im-
pact unless great care is taken to establish the purposes
and likely consequences of assessments [13,18]. For ex-
ample, an assessment system that resulted in more dis-
semination in general, as opposed to more targeted
dissemination of relevant knowledge, would be repeating
the dangers of increasing the overload on policy-makers
[105]. Where indicators are involved, they can be used as
either 'dials' to measure inputs and outputs accurately, or
as 'tin openers' to identify issues needing further examina-
tion or to aid judgement [142]. Although the use of nu-
merical indicators as dials has been advocated by some, in
an area such as the assessment of research and its utilisa-
tion in policy-making, where measurements are so diffi-
cult to make, caution is usually recommended
[13,18,142]. It would seem only sensible to use indicators
as tin openers to aid judgements when the purpose of the
assessment involves funding decisions.
Even when funding is not an issue, if any comparisons, es-
pecially international, are to be made, there would be
dangers in using simple indicators outside of a wider qual-
itative assessment. They would become de-contextualised.
The long-standing fears about such an assessment process
include the danger of manipulation through collusionPage 19 of 28
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grammes with a different composition of user groups
[13]. Depending on the purpose of the assessment there
is, nevertheless, scope for innovative thinking in terms of
methods.
Methods for assessment of research utilisation in policy-
making
Appropriate methods for assessment therefore have to be
developed to reflect:
• the purposes for which the assessment is to be conduct-
ed, for example, to increase accountability, or to support
advocacy for health research;
• the analysis about the various types of research, the
range of utilisation possibilities, and the wider conceptual
frameworks, for example, the interfaces and receptors
model; and
• the different roles that can be played by retrospective as-
sessments and ones that focus on the current position.
Various lists have been produced of the type of informa-
tion that could be gathered to produce numerical
indicators to inform either self-evaluation/peer review of
research teams [136], or to inform regular monitoring of
the benefits from work originating from a particular
health research funder [12,18]. Items from these lists rele-
vant for policy-making include a numerical record of:
presentations to policy-makers; production of fact sheets;
membership of advisory committees; and membership of
committees issuing a policy document or a treatment
guideline. These are not really measures of actual impact
and although one such measure, references in policy pub-
lications, was also proposed, the list would probably need
to be supplemented; in the case of regular monitoring, for
example, by a set of structured case studies. When an eval-
uation within a country is to be used for making funding
decisions, it would be unwise to use the numerical indica-
tors as dials because of the contextual issues and possible
biases described above. Instead they should be used to in-
form judgements.
Nor would it be sensible to use such indicators in any
cross-national comparative study unless they were in-
forming wider qualitative studies. Furthermore, to under-
stand the peculiar difficulties of using raw questionnaire
data in relation to assessing research utilisation in policy-
making on specific issues, it is helpful to return to the def-
inition of policy-making given earlier. This emphasised
that those who make policies are in a particular, authori-
tative, position. This presents a rather different set of cir-
cumstances from those encountered when assessing
utilisation of specific findings by practitioners and mem-
bers of the public. In such cases a sample might be
thought to be representative of a wider group, and indi-
vidual characteristics and circumstances might even out
within the sample. Moreover, it could be claimed that the
opinions of each practitioner or member of the public are
equally valid as regards the influence of research upon
their own behaviour. In a study of policy-making on a
specific issue, by contrast, the interviewees or question-
naire respondents will be likely to include some represent-
atives from relevant interest groups, commentators, and
researchers as well as policy-makers with varying degrees
of involvement in different aspects of the making of that
policy. In relation to understanding the processes in-
volved in the policy-making, therefore, the respondents
might have conflicting views that do present truthful rep-
resentations of what people saw and heard. Nevertheless,
depending on the respondent's degree of involvement
with the specific events under consideration, these views
are likely to be of varying validity in relation to providing
an account of the key actions.
Such complexities no doubt help explain why qualitative
interviewing and documentary analysis were used most
frequently the research utilisation studies described in the
review of previous work. Questionnaires could provide
some information from a wider range of informants than
it might be possible to interview. They could also be used
to help identify aspects on which to focus detailed parts of
the interviewing. In-depth interviews, however, are widely
seen as the most appropriate method when there is a need
to unravel situations with diverse layers and subtle nuanc-
es. According to Rossi et al, 'whereas written surveys and
questions might be useful for some limited purposes, that
approach lacks the flexibility to tailor the line of discus-
sion to the expertise of the individual, probe and explore
issues in depth, and engage the informant in careful reflec-
tion' [143]. The growth of health policy and systems re-
search suggests there is an increasing number of
researchers who could undertake such interviewing [122].
Our review of previous studies demonstrated the great dif-
ficulties of making generalisations about specific factors
associated with high levels of utilisation. To address this
in any cross-national initiative it would be useful to adopt
several strategies. First, as far as possible, structure all the
assessment studies around a conceptual framework such
as the interfaces and receptor framework presented earlier
in the report. The framework is probably sufficiently
broad to allow it to be applied to many situations. It
would, nevertheless, help inform any interview schedule
so as to ensure the questions were focusing on both how
research findings were communicated across the interfac-
es, and the degree of policy-maker receptivity to them.
This would be done not to provide a check-list of items
that it is expected would all have to be present if researchPage 20 of 28
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interview covered a range of items, some of which might
emerge as the reasons linked to utilisation, or lack of it, in
each particular study.
The second strategy would be to base the studies on com-
mon policy themes as far as possible. Possible specific
topics within the areas identified in the previous section
include multi-drug therapy for leprosy and equitable ac-
cess to health services. For each of the common themes, a
key body of international research would be identified
and some of the analysis would relate to that, and some to
the impact of the full body of research available to policy-
makers in the specific country. Some of the potential pur-
poses the WHO might have in conducting such a cross-na-
tional assessment were set out above. An approach that
uses common elements in several detailed studies, but
which also expects each study to produce its own narrative
or story of what caused research utilisation in the particu-
lar situation and context, has similarities to broader ap-
proaches to the study of innovation and organisational
change [144].
Analysis of documents and semi-structured interviews
would appear to be appropriate methods to use in a
retrospective study of research impact on policy-making
related to specific issues, especially where the policy is
made at national or sub-national government level. In-
deed, the recently conducted systematic review recom-
mended that future research in this field, 'should combine
interviews with document analysis' [22]. Questionnaires
could also have a role, particularly in securing a wide
range of opinions about the current situation regarding
knowledge sources for research utilisation in policy-mak-
ing and the relevant HRS mechanisms. A combination of
these approaches would provide triangulation of methods
and data-sources. The account below focuses particularly
on four main elements of the recommended methods for
the retrospective part of the policy-making element of the
Structured Cross-national Thematic Studies that could be
undertaken in the WHO research utilisation project [24]:
• documentary analysis;
• interviews;
• application of scales reporting the level of research utili-
sation in policy-making;
• overall analysis.
Documentary analysis
Documentary analysis would be undertaken in each
study. Initially it would be used in an attempt to identify
the degree of consistency between the policy in the coun-
try and the body of international research that is being
centrally collated by the WHO utilisation project team.
Further documentary analysis would also cover issues
such as how far policy-makers drew on research findings
in speeches during the policy formulation and implemen-
tation stages, and accounts in reports from research fund-
ing bodies of their efforts at developing mechanisms to
enhance research utilisation. The documentary data-
sources would include: research publications and reports;
legislation; administrative/executive regulations or or-
ders; reimbursement arrangements; guidelines/advice;
meeting reports and minutes (if available); policy state-
ments, speeches, and articles; and reports from research
funding bodies. A draft protocol for the first element of
the documentary analysis has been prepared (see addi-
tional file 1: Elements of a protocol for documentary
analysis).
Interviews
A stakeholder analysis could identify whom to interview
first, and then snowball techniques, together with review
of the questionnaires, would ensure other key people were
approached for an interview. In devising the semi-struc-
tured interview schedule to be used for all interviews, in
all the countries participating in a cross-national study, it
would be most important to allow interviewer flexibility.
This would be necessary to deal with local circumstances
and with situations, as described above [79], where the in-
terviewee has a much more limited conception of research
informed policy than the interviewer. Despite these cave-
ats it would also be desirable to develop a semi-structured
interview schedule that covered as many as possible of the
points discussed in the previous analysis. A draft semi-
structured interview schedule has been developed (see ad-
ditional file 2: Draft interview schedule for assessing re-
search utilisation in policy-making), but it would have to
be administered with considerable flexibility.
The interviews would allow:
• comparability across themes and countries yet sensitivi-
ty to specific contexts;
• detailed investigation of the level of research impact, in
relation to the particular issue, on the three stages of the
policy-making process: agenda setting; policy formula-
tion; and implementation;
• rolling triangulation ie using later interviews to test in-
formation gathered during earlier ones;
• investigation of key HRS and other mechanism that op-
erated at the interfaces to enhance the responsiveness of
the receptors, including: priority setting and research com-
missioning mechanisms; the creation of research centresPage 21 of 28
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funding research brokerage/translator/promoter activi-
ties; encouraging and funding reviews and syntheses of
relevant research findings and the production of policy
briefs; and facilitating interaction between researchers and
policy-makers at long-standing committees or one-off
seminars etc;
• investigation of a wide range of other relevant issues: the
role of key institutions and their mechanisms, such as pol-
icy analysis, for absorbing research and their exposure to
forces in addition to research findings; the responsiveness
of policy-makers to different types and sources of research
knowledge; the features of specific research findings that
made policy-makers more responsive to their findings; the
aspects of policy-making where research was seen as most
valuable; the role of networks, international bodies, prac-
titioner and advocacy groups, NGOs, the media and the
public in bringing research findings into the policy de-
bate; and developments in the wider political system;
• collection of data for the wider assessment in the overall
utilisation project about how far any research-informed
policy formulation and implementation was contributing
to an increase in any of the final outcomes such as health
and health equity gains.
Application of scales describing the level of research utilisation in 
policy-making
Whilst there are reservations about the extent to which nu-
merical indicators should be used for cross-national com-
parisons, it is possible to see how the type of exercises
undertaken by Buxton and Hanney [106], Jacob and Mc-
Cregor [75] and Lavis et al [11] could be built upon. It
might be possible to develop indicators in the form of de-
scriptive scales of the degree of utilisation. These would be
used to give an account of the impact of research on the
policy-making in the specific context of each of the coun-
tries participating in the WHO research utilisation project.
In the three studies cited above, the scoring or coding for
each example was undertaken by the same team. Even
clearer agreement about interpretation of scales would be
necessary in an international exercise. Before starting any
initiative, it would be desirable for the scales to be agreed
between the assessment teams in the participating
countries.
The previous analysis indicates that it would probably be
appropriate to consider developing four scales to apply to
research utilisation in each policy area. The first scale
would focus on a slightly narrower range of research that,
as noted above, would be the international research. This
would examine the consistency between the research and
the policy. Previous studies illustrate, however, that con-
sistency with research findings does not necessarily dem-
onstrate that the particular findings influenced the policy
[14]. Where the policy consists of a clinical guideline de-
veloped by a professional group there could be circum-
stances in which the first scale on the degree of
consistency, based on documentary analysis, might be the
only scale appropriate to apply. In such circumstances the
analysis should probably concentrate on the quality of the
evidence used in the guidelines [145].
The remaining three scales would each relate to assessing
the actual role played by research in each of the three
phases of policy-making described previously. The rela-
tionship between policy-making and research is often
messy and varied. Therefore, it is inevitable that some re-
search might play a part in only one of these three phases,
but other research might play several roles. For example,
epidemiological research might cause an issue to be
placed on the policy agenda, other research that devel-
oped a specific way of improving treatment could be used
in policy formulation, but might also have helped force
the issue onto the policy agenda by showing improve-
ments were possible. The details of each scale have been
prepared (see additional file 3: Draft scales of the level of
research utilisation in health policy-making). The key is-
sues covered in them are described here:
(i) Consistency of policy with research findings
This scale would relate to how far the content of the policy
on issue X was in agreement with the findings from a de-
fined body of international research (irrespective of the
actual degree of influence of research on the policy formu-
lation). It would initially be applied during the documen-
tary analysis.
(ii) Degree of influence of research on policy agenda setting
This scale would relate to the extent to which research (in-
cluding local research) had been responsible for getting
the issue onto the policy-makers' agenda. It would cover
research that: either showed the existence/extent of a
problem; or was so dramatic/decisive that it instigated ac-
tion to be taken to turn it into policy; or contained find-
ings/theoretical frameworks that gradually changed the
perception of policy-makers and others as to the impor-
tance of the issue in a process of enlightenment. It would
rely on interviews, questionnaires and documentary
analysis.
(iii) Degree of influence of research on policy formulation
This scale would relate to the actual influence the research
had in the policy formulation process. It would aim not
only to confirm any instrumental use of the research (ie
direct use of the findings or research theories in formulat-
ing the content of the policy) but also to capture examples
of the much wider range of possible impacts on policy, in-
cluding the gradual sedimentation of insights, theories,Page 22 of 28
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This scale would consider the utilisation of research both
in the actual development of the policy content, and in
policy discussions and debates. The scale would be based
primarily on the data from the interviews, but also use
survey and documentary data.
(iv) Degree of influence of research on policy implementation
The key issues for this scale would be the use of research
in assisting implementation, either through findings
which are used to inform decisions about how best to im-
plement the policy, or by providing justification of the
policy and being used to generate support for it in terms
of financial resources, political commitment, and public
opinion. The scale would be based on data primarily from
interviews and documentary analysis.
Overall analysis
The interviews, questionnaires, and documentary analysis
should also provide material to help identify the relative
importance, in relation to the level of utilisation recorded,
of each of the HRS mechanisms listed in the bullet point
above. The types and sources of research used, and
reasons for their use, should also be recorded and at-
tempts made to correlate them with the previous priority
setting approaches. It would be appropriate to enhance
the internal validity of the judgements about the list and
the scales by discussing the emerging findings with the re-
spondents. The account of each study would also involve
description both of the value given to research in the
country and of the broader cultural and socio-political en-
vironment, to the extent that they seem relevant to the de-
gree of research utilisation achieved.
The findings from the assessments in each participating
country could be collated. For each research theme the
analysis would compare two sets of data: the scales for lev-
el of utilisation in each country, and the contextualised
lists of the HRS activities and other mechanisms and net-
works thought to be important. Organising the studies
around common themes might assist assessment of how
far the use of the international stock of knowledge was de-
pendent on local research.
As noted previously, although the account here has fo-
cused on research impact on policy-making, the evalua-
tions would be stronger as part of a wider analysis
covering research utilisation and interactions with practi-
tioners, industry and the public. The fuller analysis would
be both most useful in itself, and provide greater under-
standing of the environment in which the policy-making
occurred. By building on the framework described in Fig-
ure 1, it should provide a holistic approach [112] to these
issues. Thus, the WHO research utilisation project was
conceived as an integrated whole in which retrospective
assessment of research utilisation in policy-making would
examine one step in a process that should eventually lead
to health and health equity gains [24].
Given appropriate and targeted topic and country selec-
tion, this approach is likely to meet the purpose of using
structured methods to provide examples of effective re-
search utilisation. It should contribute towards enhanced
understanding of the issues and could provide the basis of
an assessment tool which, if used widely in countries,
could give a boost to the importance attached to the utili-
sation of health research.
Conclusions
Increasing global attention is focusing on ways to improve
health systems and the contribution that research-in-
formed policies can make to this. It has long been recog-
nised that a range of factors is involved in the interactions
between health research and policy-makers. The emerging
focus on Health Research Systems (HRS) has identified
additional mechanisms through which greater utilisation
of research could be achieved. Assessment of the role of
health research in policy-making is best undertaken as
part of a wider study that also includes utilisation of
health research by industry, medical practitioners, and the
public.
The utilisation of health research in policy-making should
eventually lead to desired outcomes, including health
gains. Research can make a contribution in at least three
phases of the policy-making process: agenda setting; poli-
cy formulation; and implementation. Descriptions of
these processes, however, can over-estimate the degree of
rationality in policy-making. Therefore, the analysis
should be informed by a review of the full range of policy-
making models. Various categories of research are likely to
be used differently in health policy-making. Applied re-
search might be more readily useable by a policy system
than basic research, but health policy-makers tend to re-
late more willingly to natural sciences than social sciences.
There also appears to be a greater chance of research being
used in clinical policies about delivering care to patients,
than in national policies on the structures of the health
service.
Models of research utilisation in policy-making start with
a link to rational or instrumental views of policy-making,
and include descriptions of how commissioned research
can help to find solutions to problems. Other models re-
late to an incrementalist view in which policy-making in-
volves a series of small steps over a long period; research
findings might gradually cause a shift in perceptions
about an issue in a process of 'enlightenment'. Interactive
models of research utilisation stress the way in which pol-
icy-makers and researchers might develop links over aPage 23 of 28
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support decisions already taken.
Many previous studies of research utilisation can provide
lessons for future assessments. Two broad approaches can
be identified. Some studies start with pieces, or pro-
grammes, of research and examine their impact. Others
consider policy on a particular topic and assess the role of
research in the policy-making. To facilitate comparison,
studies of research utilisation are best organised around a
conceptual framework. Despite that, the influence of con-
textual factors in different settings makes it difficult to
generalise. The two methods used most frequently, and
usually together, come from the qualitative tradition: doc-
umentary analysis and in-depth interviews. Question-
naires, bibliometric analysis, insider knowledge and
historical approaches have all been applied. A few recent
studies have attempted to score or scale the level of utili-
sation. The examples suggest there is a greater level of uti-
lisation and final outcomes in terms of health, health
equity, and social and economic gain than is often as-
sumed, whilst still showing much underutilisation. There
is considerable variation in the degree of utilisation, both
within and between studies.
Increasing attention is focusing on the concept of interfac-
es between researchers and the users of research. This in-
corporates the idea that there are likely to be different
values and interests between the two communities. At the
prioritisation interface there are two key questions:
whether priorities are being set that will produce research
that policy-makers and others will want to use, and
whether priorities are being set that will engage the inter-
ests and commitment of the research community.
Interactions across the interface between policy-makers
and researchers are important in transferring research to
policy-makers. This fits especially well with the interactive
model of utilisation. Actions by individual researchers can
be useful in generating interaction, but it is desirable to
consider the role of the HRS in encouraging or facilitating
interactions, networks and mechanisms at a system-wide
level. The HRS could provide funding and organisational
support for various items including: long-term research
centres; research brokerage/translator mechanisms; the
creation of official committees of policy-makers and re-
searchers; and mechanisms for review and synthesis of re-
search findings.
There is increased recognition of the significance of poli-
cy-makers in their role as the receptors of research. In re-
lation to the perspective of policy-makers there is a
spectrum of key questions. These range from whether rel-
evant research is available and effectively being brought to
their attention, to whether they are able to absorb it and
willing to use it. The HRS has a responsibility, especially
in the early parts of the spectrum, but the wider health sys-
tem also has a responsibility to create appropriate institu-
tional mechanisms and ensure there are staff willing and
able to incorporate relevant research. More attention
should be given to the role of incentives. The assessment
of utilisation becomes a key issue if rewards are to focus
on relevance as well as research excellence.
An appropriate model for assessing research utilisation in
policy-making combines analysis of two issues: the role of
receptors and the importance of actions at the interfaces.
An emphasis on the role of the receptor is necessary be-
cause ultimately it is up to the policy-maker to make the
decisions. Any assessment of the success of the HRS in re-
lation to utilisation must accept that the wider political
context is beyond the control of the HRS, but consider the
activities of the HRS, within its given context, to enhance
the utilisation of research by increasing the permeability
of the interfaces.
The reasons for assessing the utilisation of research in pol-
icy-making include: advocacy, accountability, and in-
creased understanding. For the World Health
Organization there could be a role in conducting such as-
sessments with the aim of providing evidence of the effec-
tive use of research resources. This could support advocacy
for greater resources to be made available for health re-
search. It is important that the purposes of any assessment
are taken into account in planning the methods to be
used.
Previous studies demonstrated the difficulties of making
generalisations about specific factors associated with high
levels of utilisation. To address this in any cross-national
WHO initiative involving a series of studies in a range of
countries, it would be desirable to structure all the studies
around a conceptual framework (such as the interfaces
and receptor framework considered here) and base the
studies in each country on common themes. These could
include policies for the adoption of multi-drug therapy for
treating leprosy, and for the equitable access to health
services.
Analysis of documents and semi-structured interviews
would be appropriate methods in each study assessing the
role of research in policy-making on a specific policy
theme. Surveys could also have a role. These approaches
would provide triangulation of methods and data-sources
and should also provide material to help identify the rel-
ative importance, in relation to the level of utilisation re-
corded, of the HRS mechanisms described in the previous
analysis. The types and sources of research used, and rea-
sons for their use, should also be recorded and attempts
made to correlate them with the previous priority settingPage 24 of 28
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own narrative or story of what caused utilisation in the
particular context, but the data gathered could also be ap-
plied to descriptive scales of the level research utilisation.
The four scales could cover the consistency of policy with
research findings, and the degree of influence of research
on agenda setting, policy formulation, and
implementation.
The findings from the assessments in each participating
country should be collated. For each policy theme or topic
the analysis would compare two sets of data: the scales for
level of research utilisation in each country, and the con-
textualised lists of the HRS activities and other mecha-
nisms and networks thought to be important. Although
the account here has focused on research impact on poli-
cy-making, the evaluations would be stronger as part of a
wider analysis covering research utilisation and interac-
tions with practitioners, industry and the public.
Given appropriate and targeted topic and country selec-
tion, this approach is likely to meet the purpose of using
structured methods to provide examples of effective re-
search utilisation. The approach should contribute to-
wards enhanced understanding of the issues and could
provide the basis of an assessment tool which, if used
widely in countries, could lead to greater utilisation of
health research.
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